Covered recipient · General Payments record
AMAN SHAH
Allopathic & Osteopathic Physicians Emergency Medicine
General Payments · PY2019–2024
$20,871.02
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $16,531.25 | 12 |
| Travel and Lodging | $1,331.58 | 4 |
| Food and Beverage | $141.88 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $17,985.94 | 17 |
| ABBVIE INC. | $18.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $575.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434897 | CMS |
| Abbott Laboratories | $575.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434899 | CMS |
| Abbott Laboratories | $1,293.75 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434901 | CMS |
| Abbott Laboratories | $575.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434903 | CMS |
| Abbott Laboratories | $431.25 | 02/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434905 | CMS |
| Abbott Laboratories | $123.11 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125279104 | CMS |
| Abbott Laboratories | $1,150.00 | 05/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434907 | CMS |
| Abbott Laboratories | $4,312.50 | 05/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434909 | CMS |
| Abbott Laboratories | $1,437.50 | 07/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434911 | CMS |
| Abbott Laboratories | $2,300.00 | 07/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434913 | CMS |
| Abbott Laboratories | $862.50 | 07/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434915 | CMS |
| Abbott Laboratories | $1,150.00 | 07/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125434917 | CMS |
| Abbott Laboratories | $142.74 | 07/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125434919 | CMS |
| Abbott Laboratories | $29.82 | 07/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125434921 | CMS |
| Abbott Laboratories | $9.02 | 07/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125434927 | CMS |
| Abbott Laboratories | $2,300.00 | 11/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434923 | CMS |
| Abbott Laboratories | $718.75 | 11/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125434925 | CMS |
| ABBVIE INC. | $18.77 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106062416 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.